Sofwave Medical Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: IL0011754392

ILS

39.07

0.04 (0.1%)

Mar 25

TAE

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Sofwave Medical Ltd.

Why is Sofwave Medical Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%

Poor long term growth as Net Sales has grown by an annual rate of 194.30% and Operating profit at -3.79% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 150.45%, its profits have risen by 45% ; the PEG ratio of the company is 13.2

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Sofwave Medical Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Sofwave Medical Ltd.

150.45%

2.99

42.15%

Israel TA-100

67.12%

3.88

17.32%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

194.30%

EBIT Growth (5y)

-3.79%

EBIT to Interest (avg)

-3.50

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.81

Sales to Capital Employed (avg)

2.13

Tax Ratio

9.46%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

599

Industry P/E

Price to Book Value

13.68

EV to EBIT

131.31

EV to EBITDA

76.04

EV to Capital Employed

161.64

EV to Sales

4.31

PEG Ratio

13.23

Dividend Yield

ROCE (Latest)

123.10%

ROE (Latest)

2.28%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

Bearish

Bollinger Bands

Mildly Bullish

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Dow Theory

No Trend

Mildly Bullish

OBV

No Trend

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend